Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-06-18
1993-03-30
Cashion, Jr, Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 15, 530326, 530327, 530328, A61K 3700, A61K 3702, C07K 500, C07K 700
Patent
active
051984253
ABSTRACT:
Disclosed herein are peptides of the formula
REFERENCES:
patent: 4814432 (1989-03-01), Freidinger et al.
B. van't Riet, "Synthesis of Hydroxy-and Amino-Substituted Benzohydroxamic Acids: Inhibition of Ribonucleotide Reductase and Antitumor Activity", J. Med. Chem. 22(5): 589-592 (1979).
Gaudreau et al., "Structure-Activity Studies on Synthetic Peptides Inhibiting Herpes Simplex Virus Ribonucleotide Reductase", J. Biol. Chem. 262(26): 12413-12416 (1987).
Spector et al., "2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a Potent Inactivator of Ribonucleotide Reductases of Herpes Simplex and Varicella-Zoster Viruses and a Potentiator of Acyclovir", Proc., Natl. Acad. Sci. USA 86: 1051-1055 (1989).
Cosentino Gregory P.
Plante Raymond
Rakhit Sumanas
Bio-Mega Inc.
Cashion, Jr Merrell C.
Davenport A. M.
Frankhouser David E.
Reitenbach Daniel
LandOfFree
Inhibitors of bacterial ribonucleotide reductase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of bacterial ribonucleotide reductase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of bacterial ribonucleotide reductase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1281104